1[1] The tricontinental mycophenolate mofetil renal transplantation study group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation[J]. Transplantation 1996; 61: 1029-37.
2[2] Platz KP, Sollinger HW, Hullett DA, et al. RS-61443, a new, potent immunosuppressive agent[J]. Transplantation 1991; 51: 27-31.
3[3] Ahsan N, Holman MJ, Katz DA, et al. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy[J]. Clinical Transplantation 1992; 51: 428-32.
4[4] The mycophenolate mofetil renal refractory rejection study group. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection[J]. Transplantation 1996; 61: 722-9.
5Byrne E, Kornberg AJ, Kapsa R, et al.Duchenne musculare dystrophy: hopes for the sesquicentenary.Med J Aust, 2003, 179(9): 463-464.
6Wagner KR, Hamed S, Hadley DW, et al.Gentamycin treatment of Duchenne muscular dystrophy due to nonsence mutation.Ann Neurol, 2001, 49(6): 706-711.
8Fenichel GM, Griggs RC, Kissel J, et al.A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne muscular dystrophy.Neurology, 2001, 56(8): 1075-1079.
9Fowler EG, Greves MC, Wetzel GT, et al.Pilot trial of albuterol in Duchenne and Becker muscular dystrophy.Neurology, 2004, 62(6): 1006-1008.
10Kinali M, Mercuri E, Main M, et al.Pilot study of albuterol in spinal muscular atrophy.Neurology, 2002, 59(4): 609-610.
5Sehneider -- GoldC, HartungHP, GoldR. MyeoPhenolate mofetil and taerolimus: new therapeutic options in ncuroimmunological diseases [J]Muscle Nerve.2006, 34:284-291.
6MitsuiT, KunishigeM, IehimiyaM, etal. Benefieial effect of taerolimus on myasthenia gravis with thymoma[J].Neurologist, 2007, 13:83 - 86.
7PonsetiJM, AzemJ, ForrJMetal. Experience with starting Taerolimus postoperatively after transstemal extended thymeetomy in patients with myasthenia gravls[J]. Curr Med Res OPin2006, 22:885 - 895.
8ShimOJima Y, Matsuda M.Gono T, et al. Tacrolimus in refraetory Patients with myasthenia gravis:eoadministration and tapering of oral prednisolone[J]. J Clin Neurosei, 2006, 13:39 - 44.
9PonseflJM, AzemJ, FortJM residual, eyclosporin -- and gravis:one -- year follow -- up etal.Benefits of FK506(raerolimus) for Prednisone -- resistant myasthenia of an open -- label study[J].ClinNeurol Neurosurg, 2005, 107:187-190.
10YoshikawaH, MabuehiK, YasukawaY, et al. Low -- dose taerolimus for Intraetable myasthenla gravls[JI. J Clin Neurose-, 2002, 9:627 - 628.
